Vancouver, British Columbia--(Newsfile Corp. - May 9, 2017) - THC BioMed (CSE: THC) (OTCQB: THCBF) (FSE: TFHC) has closed its
previously announced acquisition of U.S. based Clone Shipper LLC, acquiring 100% of the shares of Clone Shipper at a cost of US$1
million.
InvestmentPitch.com has produced a "video"
which discusses this news. If this link is not enabled, please visit www.InvestmentPitch.com and enter "THC BioMed" in the search box. The video is also
available on YouTube.
The company is using the newly designed Clone Shipper 3.0 containers to ship live cannabis plants across Canada and believes it
is the one of the first companies in Canada to ship live cannabis plants. The patented design allows for a LED light to keep the
clone in the growing vegetative stage for 12 to 24 hours during shipment.
Management believes that Clone Shipper is currently the only device that meets Canadian and Federal International laws governing
the transportation of live, controlled substance plants, and has launched a separate product called "THC Clone Shipper"
specifically designed to meet these regulations. The products are available for sale through www.thcbiomed.com or www.cloneshipperunit.com.
John Miller, President & CEO, stated: "The Global demand for securely shipping live plants is increasing with the
legalization of Medical Cannabis. This is the early formation of our presence within the international Cannabis market place. We
look forward being a part of every Cannabis live plant that is shipped Globally. We will vigorously protect any infringements on
our patents and continue to register patents worldwide."
With the Canadian government moving toward the legalization of recreational marijuana, the company expects that home growing
will play a major role in alleviating a potential supply shortage. To fill the need for live plants, THCBioMed is expanding, and
has developed a product that will grow under the most stressful conditions. It has developed strains with a distinct herbal odor,
resulting in a product which exhibits a less pungent marijuana smell when smoked.
John Miller further commented: "We want to deliver the most potent, cleanest, clearest product in every aspect. We look
forward to introducing our THC Sativa Strain. It is a landrace strain with high levels of THCV. THCV, a Cannabinoid that is rarely
spoken about or researched, is only found in certain strains, and THC believes that this cannabinoid will become very important in
the future."
THC BioMed currently ships the most live Cannabis plants in Canada, and has the widest selection of strains available. It
anticipates introducing its dried marijuana products at $4.20 per gram by the third quarter, a price which reflects the company's
mandate to provide patients with accessibility to medical cannabis.
For more information, please visit www.THCbiomed.com, contact
John Miller, President & CEO, at 1-844-THCMEDS or email info@THCbiomed.com.
About InvestmentPitch Media
Investmentpitch Media leverages the power of video, which together with its extensive distribution, positions a company's story
ahead of the 1,000's of companies seeking awareness and funding from the financial community. The company specializes in producing
short videos based on significant news releases, research reports and other content of interest to investors.
CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com
